The FDA announced on Oct. 28, 2015, that Sanofi-Aventis U.S. LLC voluntarily recalled Auvi-Q epinephrine auto-injectors due to a defective delivery system that may result in inaccurate dosage. The agency issued recall number D-0872-2016 for the Class I product.
How to tell if you have it
- Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg
- NDC 0025-5833-02: 2 prefilled auto injectors + 1 trainer
- NDC 0024-5833-00: 1 prefilled auto injector + 1 trainer
- Lot codes: 2081278, 2113841, 2113842, 2144138 (exp 10/2015); 2440675 (exp 04/2016); 2506456, 2506460, 2546946, 2546947 (exp 05/2016); 2620206, 2620207, 2659534 (exp 06/2016); 2692111, 2692112 (exp 07/2016); 2716517, 2719817, 2734079, 2734080, 2734081, 2778035, 2800128 (exp 08/2016); 2800130, 2824828, 2824829, 2857516, 2867928, 2870928, 2867929, 2867930, 2883616, 2883617 (exp 09/2016); 2883618, 2883619, 2974267, 2883620, 2945419, 2974269 (exp 10/2016); 3026968, 3026969 (exp 11/2016); 3026970, 3028227, 3032005, 3037217, 3037218, 3037219 (exp 12/2016); 2299596 (exp 03/2016)
- Nationwide distribution
The hazard
The recall addresses a defective delivery system in the Auvi-Q auto-injectors that poses a potential for inaccurate dosage delivery. The FDA classified this as a Class I recall, indicating the highest degree of hazard.
Context
GovInfoNow's records show Sanofi-Aventis U.S. LLC has had 9 other recalls on record since 2016-09-01. Other recent recalls of similar products include Fresenius Kabi Epinephrine Injection Recall (2026-05-14), EPINEPHR Sterility Risk in 1 mg/10mL Injection Recall (2026-04-01), and ANI Pharmaceuticals Recalls Estradiol Gel Due to Defective Containers (2026-05-12).